Rehabilitation of motor function after stroke: a multiple systematic review focused on techniques to stimulate upper extremity recovery

SM Hatem, G Saussez, M Della Faille, V Prist… - Frontiers in human …, 2016 - frontiersin.org
Stroke is one of the leading causes for disability worldwide. Motor function deficits due to
stroke affect the patients' mobility, their limitation in daily life activities, their participation in …

Post-stroke depression: mechanisms and pharmacological treatment

RF Villa, F Ferrari, A Moretti - Pharmacology & therapeutics, 2018 - Elsevier
Depression, the most frequent psychiatric disorder following ischaemic stroke, negatively
affects survivals' functional outcome, response to rehabilitation and quality of life …

Poststroke depression: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association

A Towfighi, B Ovbiagele, N El Husseini, ML Hackett… - Stroke, 2017 - Am Heart Assoc
Poststroke depression (PSD) is common, affecting approximately one third of stroke
survivors at any one time after stroke. Individuals with PSD are at a higher risk for suboptimal …

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

GJ Hankey, ML Hackett, OP Almeida, L Flicker… - The Lancet …, 2020 - thelancet.com
Background Trials of fluoxetine for recovery after stroke report conflicting results. The
Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral …

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial

F Chollet, J Tardy, JF Albucher, C Thalamas… - The Lancet …, 2011 - thelancet.com
Background Hemiplegia and hemiparesis are the most common deficits caused by stroke. A
few small clinical trials suggest that fluoxetine enhances motor recovery but its clinical …

Neuronal plasticity and neurotrophic factors in drug responses

E Castrén, H Antila - Molecular psychiatry, 2017 - nature.com
Neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF) and other
members of the neurotrophin family, are central mediators of the activity-dependent plasticity …

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

GE Mead, CF Hsieh, R Lee… - Cochrane Database …, 2012 - cochranelibrary.com
Background Stroke is the major cause of adult disability. Selective serotonin reuptake
inhibitors (SSRIs) have been used for many years to manage depression. Recently, small …

Post‐stroke depression: mechanisms, translation and therapy

I Loubinoux, G Kronenberg, M Endres… - Journal of cellular …, 2012 - Wiley Online Library
The interaction between depression and stroke is highly complex. Post‐stroke depression
(PSD) is among the most frequent neuropsychiatric consequences of stroke. Depression …

[HTML][HTML] Potential mechanisms and clinical effectiveness of acupuncture in depression

NN Yang, LL Lin, YJ Li, HP Li, Y Cao… - Current …, 2022 - ncbi.nlm.nih.gov
Major depressive disorder is the most common mental disorder with significant economic
burden and limited treatments. Acupuncture has emerged as a promising non …

Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors

JD Gray, TA Milner, BS McEwen - Neuroscience, 2013 - Elsevier
Brain-derived neurotrophic factor (BDNF) is a secreted protein that has been linked to
numerous aspects of plasticity in the central nervous system (CNS). Stress-induced …